web

Vitiligo news from the web

Ra Medical Systems introduces new dermatology excimer laser for the treatment of patients with psoriasis, vitiligo, and atopic dermatitis.

1 year ago

Is fruit good or bad for vitiligo?

1 year ago

Results ‘promising’ in phase 2 study of ruxolitinib cream for patients with vitiligo

1 year ago

another article on the antibody blockade of il-15 on dermatology times

1 year ago

mutant protein HSP70i, one of the best future treatments for vitiligo!

1 year ago

latest news

january 2020

Finally after months of silence we have good news about how the antibody blockade of il-15 (probably the best vitiligo treatment in clinical trial) is going, if you are wondering about the antibody blockade of il-15, last year we wrote an article about it, CLICK HERE TO READ IT.
The next phase of clinical trials was supposed to begin last summer 2019, but unfortunately this got delayed and most of us who are following this development were disappointed and curious about it. In this regard, Dr Harris posted an article on his blog explaining the situation, currently the next phase clinical trial will begin in spring 2020 if there are no further delays. The good news is fundings were granted and many investors are very interested in this drug as it is proving very promising! To avoid creating too much excitement though, let me remind you it will still be a few years before it will be on the market, it will not be available tomorrow or next year, but it’s something to wait for. Happy new years dear vitiligans!

web

Ra Medical Systems introduces new dermatology excimer laser for the treatment of patients with psoriasis, vitiligo, and atopic dermatitis.

Is fruit good or bad for vitiligo?

Results ‘promising’ in phase 2 study of ruxolitinib cream for patients with vitiligo

another article on the antibody blockade of il-15 on dermatology times

mutant protein HSP70i, one of the best future treatments for vitiligo!

You may missed

T-cells and vitiligo: Could new cancer research hold the key to a cure?

Topical Ruxolitinib begins phase 3 clinical trials with first vitiligo patient being treated with the first topical jak inhibitor

The effect of age on vitiligo – Thevitpro analyzes the differences of vitiligo based on age onset, and the fact that both genetic and environmental factors play a role with it.

Anxiety And Skin Issues – Emotional stress and anxiety may aggravate any chronic skin diseases can initiate a vicious cycle referred to as the itch-scratch cycle

Tulsa Teen with vitiligo starts support group for rare skin conditions